08:50 AM EST, 01/30/2026 (MT Newswires) -- Avicanna ( AVCNF ) said Friday that a medical cannabis real-world evidence (MCRWE) study has been published in the peer-reviewed Canadian Journal of Pain.

The prospective, observational study, conducted through Avicanna's ( AVCNF ) MyMedi.ca platform, gauged patient-reported outcomes among individuals with chronic pain receiving physician-authorized medical cannabis in routine clinical practice. The study was led by Dr. Hance Clarke at the University Health Network (UHN) and supported by several other clinicians and medical institutions.

"While the term 'medical cannabis' is widely used, this study specifically evaluated outcomes among patients using medical cannabis under the supervision of a health-care provider," said Dr. Clarke, principal investigator.

A statement noted the magnitude of change did not meet established minimal clinically important difference thresholds but the results highlight the need for more placebo-controlled randomized trials to better define optimal dosing strategies, formulations, and routes of administration for medical cannabis.